Keywords

• Thymalfasin
• Thymalfasin Acetate
• 69440-99-9

Quick Details

• ProName: Thymalfasin
• CasNo: 69440-99-9
• Molecular Formula: C129h215n33o55
• Appearance: white powder
• Application: Thymalfasin
• DeliveryTime: 5 days
• PackAge: Vial or customized
• Port: Shanghai, Beijing, Shenzhen etc.
• ProductionCapacity: 100 Kilogram/Month
• Purity: 99%
• Storage: 2-8℃ sealed and away from light
• Transportation: Ocean and air shipping
• LimitNum: 10 Milligram
• Related Substances: Effective ingredients >99%
• Residue on Ignition: 0.1
• Heavy Metal: 0
• Valid Period: 3 years

Superiority

GMP Manafacturer

High Purity

Competitive Price

Short Delivery Time

Our Thymalfasin is not limited to treating infectious diseases. It also shows great potential in the management of various cancers. It can enhance the anti - tumor immune response, making it a beneficial adjunct to traditional cancer treatments. Additionally, in autoimmune diseases, Thymalfasin helps to regulate the over - active immune response, bringing relief to patients with conditions like rheumatoid arthritis and systemic lupus erythematosus.

Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.

Details

Thymalfasin:
CAS No.: 69440-99-9
Sequence: 
Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn.
Thymalfasin is a protein and peptide hormone with immune enhancement function produced by superficial thymic cortex and medullary epithelial cells.It is a biological response modifier with relatively high biological activity. It is widely used clinically for the treatment of immunodeficiency, viral infections and tumors. It is a confirmed first-line drug for the treatment of hepatitis B. It can also be used as a vaccine adjuvant drug with significant therapeutic effects.

Company Profile 

Founded in 2011, Harbin Jixianglong Biotech Co., Ltd. is a is a professional high-tech company specializing in R&D and production of polypeptide pharmaceuticals. Our advanced industry chain occupied in R&D, approbation and industrialization of peptides API and preparation.
Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.
Jixianglong has 10 APIs production approvals, 16 invention patents achieved, including 5 compound patents.